Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 May 15;31(3):334-336.
doi: 10.1080/08998280.2018.1460130. eCollection 2018 Jul.

Anabolic androgenic steroid-induced acute myocardial infarction with multiorgan failure

Frederick J Flo  1 , Obiajulu Kanu  2 , Mohamed Teleb  3 , Yuefeng Chen  3 , Tariq Siddiqui  3
Affiliations
Case Reports

Anabolic androgenic steroid-induced acute myocardial infarction with multiorgan failure

Frederick J Flo et al. Proc (Bayl Univ Med Cent). .

Abstract

The abuse of anabolic androgenic steroids (AAS) has remained on the rise despite their well-known deleterious effects. We describe a case of AAS-induced multisystem failure following an extensive history of abuse in a 41-year-old bodybuilder. Furthermore, we review pertinent literature and discuss the different pathophysiologic mechanisms through which AAS affect the heart and other organs. This case points to the possibility of multiorgan involvement and severe cardiac effects of AAS abuse in young individuals who may not have any past medical history.

Keywords: Acute coronary syndrome; acute myocardial infarction; anabolic steroid abuse; multiorgan failure; subclinical congestive heart failure; testosterone replacement therapy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Chest x-ray (anteroposterior view) showing cardiomegaly with no evidence of congestive heart failure.
See this image and copyright information in PMC

References

    1. Shamloul RM, Aborayah AF, Hashad A, Abd-Allah F. Anabolic steroids abuse–induced cardiomyopathy and ischaemic stroke in a young male patient. BMJ Case Rep . 2014;2014. doi:10.1136/bcr-2013-203033. PMID:24574525. - DOI - PMC - PubMed
    1. O'Sullivan AJ, Kennedy MC, Casey JH, Day RO, Corrigan B, Wodak AD. Anabolic–androgenic steroids: medical assessment of present, past and potential users. Med J Aust. 2000;173:323–327. PMID:11061405. - PubMed
    1. Thiblin I, Petersson A. Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol . 2005;19:27–44. doi:10.1111/j.1472-8206.2004.00298.x. PMID:15660958. - DOI - PubMed
    1. Melchert RB, Welder AA. Cardiovascular effects of androgenic–anabolic steroids. Med Sci Sports Exerc . 1995;27:1252–1262. doi:10.1249/00005768-199509000-00004. PMID:8531623. - DOI - PubMed
    1. Kuhn CM. Anabolic steroids. Recent Prog Horm Res . 2002;57:411–434. doi:10.1210/rp.57.1.411. PMID:12017555. - DOI - PubMed

Publication types

LinkOut - more resources